Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Szombathely – page 9

173 clinical trials in Szombathely, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Szombathely at a glance
173
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

173 trials in Szombathely

Open in trial search

Study of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Merck Sharp & Dohme LLC

Psoriatic arthropathy

Not recruiting

Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Study on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Pharmacosmos A/S

Atrial fibrillation

Not recruiting

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:HungaryHungary
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Astrazeneca AB

Study on the Effects of FDY-5301 for Patients with Anterior ST-Elevation Myocardial Infarction (Heart Attack)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Iodide
  • Sponsor:Faraday Pharmaceuticals Inc.

Cardiac failure+1

Not recruiting

Study of LY3540378 for Adults with Worsening Chronic Heart Failure with Preserved Ejection Fraction

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Volenrelaxin
  • Sponsor:Eli Lilly & Co.

A study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Szombathely

What the registry says about research in the country

01 Respiratory Medicine

Clinical trials focusing on respiratory conditions, particularly investigating new treatments for asthma and COPD. Studies evaluate innovative therapies including atuliflapon and dupilumab for improving lung function and disease control.

  • Moderate to severe asthma management
  • COPD treatment optimization
  • Lung function preservation

Research aims to enhance therapeutic options for patients with uncontrolled respiratory conditions.

02 Dermatology & Immunology

Innovative research in inflammatory skin conditions and immune-mediated disorders, including studies on atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa.

  • Advanced biologics evaluation
  • Inflammatory disease management
  • Novel therapeutic approaches

Studies focus on developing targeted treatments for chronic inflammatory conditions.

03 Oncology & Hematology

Groundbreaking research in cancer treatment and blood disorders, including studies on breast cancer, lymphoma, and multiple myeloma. Investigations of targeted therapies and combination treatments.

  • Breast cancer therapy
  • Lymphoma treatment
  • Multiple myeloma management

Focus on improving survival rates and treatment outcomes in various cancer types.

04 Gastroenterology

Clinical research examining treatments for inflammatory bowel diseases, including studies on Crohn's Disease and Ulcerative Colitis. Evaluation of combination therapies and novel biological agents.

  • IBD treatment advancement
  • Combination therapy assessment
  • Disease control optimization

Emphasis on improving quality of life for patients with chronic digestive conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.